W. Lee, O. Connell, C. Baskett, and T. , Maternal and Perinatal Outcomes of Eclampsia: Nova Scotia, 1981-2000, Journal of Obstetrics and Gynaecology Canada, vol.26, issue.2, pp.119-123, 1981.
DOI : 10.1016/S1701-2163(16)30487-X

L. Haukkamaa, M. Salminen, H. Laivuori, H. Leinonen, V. Hiilesmaa et al., A) Representative Western blot analysis of ADRB3 expression in plasma membranes from placental arteries obtained in normotensive (n ¼ 3) and preeclamptic (n ¼ 3) women. Expected size for ADRB3 is 68 kDa. Homogenate of CHO cells transfected with the human ADRB3 (ADRB3- CHO) was used as a positive control. B) Analysis of the expression of ADRB3 immunoreactive protein in placental arteries obtained from normotensive and preeclamptic women. The ADU represents the intensity of the bands evaluated by densitometry, Each bar represents the mean 6 SEM from three different normotensive and three different preeclamptic women

J. Granger, B. Alexander, M. Llinas, W. Bennett, and R. Khalil, Pathophysiology of Preeclampsia: Linking Placental Ischemia/Hypoxia with Microvascular Dysfunction, Microcirculation, vol.9, issue.3, pp.147-160, 2002.
DOI : 10.1038/sj.mn.7800137

C. Bertrand, L. Duperron, and J. St-louis, Umbilical and placental vessels: Modifications of their mechanical properties in preeclampsia, American Journal of Obstetrics and Gynecology, vol.168, issue.5, pp.1537-1546, 1993.
DOI : 10.1016/S0002-9378(11)90795-9

B. Sibai, G. Dekker, and K. M. Preeclampsia, Pre-eclampsia, The Lancet, vol.365, issue.9461, pp.785-799, 2005.
DOI : 10.1016/S0140-6736(05)71003-5

R. Levine, R. Thadhani, C. Qian, C. Lam, K. Lim et al., Urinary Placental Growth Factor and Risk of Preeclampsia, JAMA, vol.293, issue.1, pp.77-85, 2005.
DOI : 10.1001/jama.293.1.77

R. Thadhani, W. Mutter, M. Wolf, R. Levine, R. Taylor et al., First Trimester Placental Growth Factor and Soluble Fms-Like Tyrosine Kinase 1 and Risk for Preeclampsia, The Journal of Clinical Endocrinology & Metabolism, vol.89, issue.2, pp.770-775, 2004.
DOI : 10.1210/jc.2003-031244

I. Manyonda, D. Slater, C. Fenske, D. Hole, M. Choy et al., A role for noradrenaline in pre-eclampsia: towards a unifying hypothesis for the pathophysiology, BJOG: An International Journal of Obstetrics and Gynaecology, vol.104, issue.6, pp.641-648, 1998.
DOI : 10.1016/0301-2115(95)02511-1

B. Aune, A. Vartun, P. Oian, and G. Sager, Evidence of dysfunctional beta2-adrenoceptor signal system in pre-eclampsia, BJOG: An International Journal of Obstetrics and Gynaecology, vol.7, issue.1, pp.116-121, 2000.
DOI : 10.1056/NEJM199611143352002

L. Emorine, S. Marullo, M. Briend-sutren, G. Patey, K. Tate et al., Molecular characterization of the human beta 3-adrenergic receptor, Science, vol.245, issue.4922, pp.1118-1121, 1989.
DOI : 10.1126/science.2570461

J. Granneman, K. Lahners, and A. Chaudhry, Characterization of the human b 3 -adrenergic receptor gene, Mol Pharmacol, vol.44, pp.264-270, 1993.

A. Strosberg, Structure, function, and regulation of adrenergic receptors, Protein Science, vol.83, issue.8, pp.1198-1209, 1993.
DOI : 10.1002/pro.5560020802

J. Arch, A. Ainsworth, M. Cawthorne, V. Piercy, M. Sennitt et al., Atypical ??-adrenoceptor on brown adipocytes as target for anti-obesity drugs, Nature, vol.143, issue.5964, pp.163-165, 1984.
DOI : 10.1038/309163a0

M. Bardou, B. Dousset, C. Deneux-tharaux, C. Smadja, E. Naline et al., In vitro inhibition of human colonic motility with SR 59119A and SR 59104A: evidence of a ??3-adrenoceptor-mediated effect, European Journal of Pharmacology, vol.353, issue.2-3, pp.281-287, 1998.
DOI : 10.1016/S0014-2999(98)00419-1

M. Bardou, C. Loustalot, J. Cortijo, B. Simon, E. Naline et al., -adrenoceptor in human near-term myometrium, British Journal of Pharmacology, vol.11, issue.8, pp.1960-1966, 2000.
DOI : 10.1038/sj.bjp.0703491
URL : https://hal.archives-ouvertes.fr/dumas-01261502

C. Rouget, M. Bardou, M. Breuiller-fouche, C. Loustalot, H. Qi et al., -Adrenoceptor Is the Predominant ??-Adrenoceptor Subtype in Human Myometrium and Its Expression Is Up-Regulated in Pregnancy, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.3, pp.1644-1650, 2005.
DOI : 10.1210/jc.2004-0233
URL : https://hal.archives-ouvertes.fr/hal-01207282

M. Berlan, J. Galitzky, A. Bousquet-melou, M. Lafontan, and J. Montastruc, b 3 - Adrenoceptor-mediated increase in cutaneous blood flow in the dog, J Pharmacol Exp Ther, vol.268, pp.1444-1451, 1994.

J. Trochu, V. Leblais, Y. Rautureau, F. Beverelli, L. Marec et al., Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta, British Journal of Pharmacology, vol.250, issue.1, pp.69-76, 1999.
DOI : 10.1038/sj.bjp.0702797

A. Strosberg, -ADRENERGIC RECEPTOR, Annual Review of Pharmacology and Toxicology, vol.37, issue.1, pp.421-450, 1997.
DOI : 10.1146/annurev.pharmtox.37.1.421
URL : https://hal.archives-ouvertes.fr/inserm-01264507

C. Rouget, M. Breuiller-fouche, F. Mercier, M. Leroy, C. Loustalot et al., -adrenoceptor is resistant to desensitisation after sustained agonist stimulation, British Journal of Pharmacology, vol.295, issue.5, pp.831-841, 2004.
DOI : 10.1038/sj.bjp.0705616
URL : https://hal.archives-ouvertes.fr/hal-01207282

C. Gauthier, V. Leblais, L. Kobzik, J. Trochu, N. Khandoudi et al., The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle., Journal of Clinical Investigation, vol.102, issue.7, pp.1377-1384, 1998.
DOI : 10.1172/JCI2191

M. Dennedy, D. Houlihan, H. Mcmillan, and J. Morrison, ??2- and ??3-Adrenoreceptor agonists: Human myometrial selectivity and effects on umbilical artery tone, American Journal of Obstetrics and Gynecology, vol.187, issue.3, pp.641-647, 2002.
DOI : 10.1067/mob.2002.125277

S. Roberts, F. Russell, P. Molenaar, and R. Summers, Characterization and localization of atypical ??-adrenoceptors in rat ileum, British Journal of Pharmacology, vol.17, issue.6, pp.2549-2556, 1995.
DOI : 10.1111/j.1476-5381.1995.tb17206.x

C. Mehats, G. Tanguy, E. Dallot, B. Robert, R. Rebourcet et al., Selective upregulation of phosphodiesterase-4 cyclic adenosine 3 0 ,5 0 monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture, Endocrinology, vol.140, pp.3228-3237, 1999.

M. Bardou, J. Cortijo, C. Loustalot, S. Taylor, A. Perales-marin et al., Pharmacological and biochemical study on the effects of selective phosphodiesterase inhibitors on human term myometrium, Naunyn-Schmiedeberg's Archives of Pharmacology, vol.360, issue.4, pp.457-463, 1999.
DOI : 10.1007/s002109900092

M. Wareing, I. Crocker, A. Warren, M. Taggart, and P. Baker, Characterization of Small Arteries Isolated From the Human Placental Chorionic Plate, Placenta, vol.23, issue.5, pp.400-409, 2002.
DOI : 10.1053/plac.2002.0825

B. Resch, E. Ducza, R. Gaspar, and G. Falkay, Role of adrenergic receptor subtypes in the control of human placental blood vessels, Molecular Reproduction and Development, vol.61, issue.2, pp.166-171, 2003.
DOI : 10.1002/mrd.10337

M. Leroy, I. Cedrin, M. Breuiller, Y. Giovagrandi, and F. Ferre, Correlation between selective inhibition of the cyclic nucleotide phosphodiesterases and the contractile activity in human pregnant myometrium near term, Biochemical Pharmacology, vol.38, issue.1, pp.9-15, 1989.
DOI : 10.1016/0006-2952(89)90142-1

J. Tamaoki, E. Tagaya, K. Isono, and A. Nagai, Atypical Adrenoceptor-Mediated Relaxation of Canine Pulmonary Artery through a cAMP-Dependent Pathway, Biochemical and Biophysical Research Communications, vol.248, issue.3, pp.722-727, 1998.
DOI : 10.1006/bbrc.1998.9047

C. Dessy, S. Moniotte, P. Ghisdal, X. Havaux, P. Noirhomme et al., Endothelial ??3-Adrenoceptors Mediate Vasorelaxation of Human Coronary Microarteries Through Nitric Oxide and Endothelium-Dependent Hyperpolarization, Circulation, vol.110, issue.8, pp.948-954, 2004.
DOI : 10.1161/01.CIR.0000139331.85766.AF

Y. Rautureau, G. Toumaniantz, S. Serpillon, P. Jourdon, J. Trochu et al., Beta 3-adrenoceptor in rat aorta: molecular and biochemical characterization and signalling pathway, British Journal of Pharmacology, vol.26, issue.Suppl. E, pp.153-161, 2002.
DOI : 10.1038/sj.bjp.0704867

J. Roberts and K. Lain, Recent Insights into the Pathogenesis of Pre-eclampsia, Placenta, vol.23, issue.5, pp.359-372, 2002.
DOI : 10.1053/plac.2002.0819

L. Groop and M. Orho-melander, The dysmetabolic syndrome, Journal of Internal Medicine, vol.106, issue.2, pp.105-120, 2001.
DOI : 10.1038/79876

E. Widen, M. Lehto, T. Kanninen, J. Walston, A. Shuldiner et al., -Adrenergic???Receptor Gene with Features of the Insulin Resistance Syndrome in Finns, New England Journal of Medicine, vol.333, issue.6, pp.348-351, 1995.
DOI : 10.1056/NEJM199508103330604
URL : https://hal.archives-ouvertes.fr/hal-00669044

A. Malina, H. Laivuori, P. Agatisa, L. Collura, W. Crombleholme et al., The Trp64Arg polymorphism of the ??3-adrenergic receptor is not increased in women with preeclampsia, American Journal of Obstetrics and Gynecology, vol.190, issue.3, pp.779-783, 2004.
DOI : 10.1016/j.ajog.2003.09.026

J. Lecrivain, J. Cohen-tannoudji, M. Robin, N. Coudouel, C. Legrand et al., Molecular Mechanisms of Adenylyl Cyclase Desensitization in Pregnant Rat Myometrium following In Vivo Administration of the ??-Adrenergic Agonist, Isoproterenol, Biology of Reproduction, vol.59, issue.1, pp.45-52, 1998.
DOI : 10.1095/biolreprod59.1.45

S. Engelhardt, W. Zieger, J. Kassubek, M. Michel, M. Lohse et al., Tocolytic therapy with fenoterol induces selective downregulation of b-adrenergic receptors in human myometrium, J Clin Endocrinol Metab, vol.82, pp.1235-1242, 1997.

A. Inayatulla, S. Chemtob, B. Nuwayhid, and D. Varma, Responses of placental arteries from normotensive and preeclamptic women to endogenous vasoactive agents, American Journal of Obstetrics and Gynecology, vol.168, issue.3, pp.869-874, 1993.
DOI : 10.1016/S0002-9378(12)90836-4

S. Ong, I. Crocker, A. Warren, and P. Baker, FUNCTIONAL CHARACTERISTICS OF CHORIONIC PLATE PLACENTAL ARTERIES FROM NORMAL PREGNANT WOMEN AND WOMEN WITH PRE-ECLAMPSIA, Hypertension in Pregnancy, vol.13, issue.10, pp.175-183, 2002.
DOI : 10.1081/PRG-120015844

M. Breuiller, B. Rouot, M. Leroy, P. Blot, L. Kaplan et al., Adrenergic Receptors in Inner and Outer Layers of Human Myometrium Near Term: Characterization of Beta-Adrenergic Receptor Sites by [¹²⁵I]-Iodocyanopindolol Binding, Gynecologic and Obstetric Investigation, vol.24, issue.1, pp.28-37, 1987.
DOI : 10.1159/000298771

D. Mostello, T. Catlin, L. Roman, W. Holcomb, . Jr et al., Preeclampsia in the parous woman: Who is at risk?, American Journal of Obstetrics and Gynecology, vol.187, issue.2, pp.425-429, 2002.
DOI : 10.1067/mob.2002.123608

T. Larsen, S. Toubro, M. Van-baak, K. Gottesdiener, P. Larson et al., Effect of a 28-d treatment with L-796568, a novel b 3 adrenergic receptor agonist, on energy expenditure and body composition in obese men, Am J Clin Nutr, vol.76, pp.780-788, 2002.

Y. Hakak, D. Shrestha, M. Goegel, D. Behan, D. Chalmers et al., Global analysis of G-protein-coupled receptor signaling in human tissues, FEBS Letters, vol.100, issue.1-3, pp.11-17, 2003.
DOI : 10.1016/S0014-5793(03)00762-2